Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05577481
PHASE2

Neuronavigation Guided iTBS With Personalized Target for Depression

Sponsor: Xijing Hospital

View on ClinicalTrials.gov

Summary

The study will compare the efficacy of intermittent Theta Burst Stimulation (iTBS) with DLPFC-pgACC personalized target for major depressive disorder (MDD) and explore possible brain network mechanisms. The stimulated targets will be located by magnetic resonance imaging (MRI) based on functional MRI based on functional connectivity respectively. This study aims to identify that functional connectivity targeted iTBS protocols on DLPFC-pgACC personalized target have a better antidepressant efficacy compared the sham group and certify that pgACC is an effective potential effector target.

Official title: Research on the Efficacy and Brain Network Mechanism of Personalized Targeting Intermittent Theta Burst Stimulation (iTBS) Based on Functional Magnetic Resonance Imaging for the Treatment of Major Depressive Disorder

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

68

Start Date

2023-07-10

Completion Date

2025-02-28

Last Updated

2026-04-27

Healthy Volunteers

No

Conditions

Interventions

COMBINATION_PRODUCT

sham iTBS combined with antidepressants

Two sessions of sham prolonged iTBS (1800 pulses) per day over 10 days combined with antidepressants.

COMBINATION_PRODUCT

iTBS combined with antidepressants

Two sessions of prolonged iTBS (1800 pulses) per day over 10 days combined with antidepressants.

Locations (1)

XijingH

Xi'an, Shaan'xi, China